Header Logo

Connection

Yahya Choonara to Drug Delivery Systems

Back to Details
This is a "connection" page, showing publications Yahya Choonara has written about Drug Delivery Systems.
Yahya Choonara
Connection Strength
13,515
Drug Delivery Systems
  1. Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS). Int J Pharm. 2024 May 25; 657:124182.
    View in: PubMed
    Score: 0,816
  2. Customized 3D printed multi-drug systems: an effective and efficient approach to polypharmacy. Expert Opin Drug Deliv. 2022 09; 19(9):1149-1163.
    View in: PubMed
    Score: 0,729
  3. Fabrication and Characterisation of a Photo-Responsive, Injectable Nanosystem for Sustained Delivery of Macromolecules. Int J Mol Sci. 2021 Mar 25; 22(7).
    View in: PubMed
    Score: 0,658
  4. Fouling in ocular devices: implications for drug delivery, bioactive surface immobilization, and biomaterial design. Drug Deliv Transl Res. 2021 10; 11(5):1903-1923.
    View in: PubMed
    Score: 0,650
  5. Improving drug delivery technology for treating neurodegenerative diseases. Expert Opin Drug Deliv. 2016 07; 13(7):1029-43.
    View in: PubMed
    Score: 0,465
  6. 3D Printing in Drug Delivery Formulation: You Can Dream it, Design it and Print it. How About Patent it? Recent Pat Drug Deliv Formul. 2015; 9(3):192-3.
    View in: PubMed
    Score: 0,427
  7. Five decades of sci-fi in drug delivery. Ther Deliv. 2013 Mar; 4(3):285-7.
    View in: PubMed
    Score: 0,376
  8. Diverse approaches for the enhancement of oral drug bioavailability. Biopharm Drug Dispos. 2011 May; 32(4):185-209.
    View in: PubMed
    Score: 0,330
  9. In vivo evaluation of a biodegradable donut-shaped minitablet for prolonged posterior segment drug delivery in the rabbit eye model. J Pharm Sci. 2011 May; 100(5):1819-32.
    View in: PubMed
    Score: 0,323
  10. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases. J Pharm Sci. 2010 May; 99(5):2219-39.
    View in: PubMed
    Score: 0,309
  11. Construction and in vitro characterization of an optimized porosity-enabled amalgamated matrix for sustained transbuccal drug delivery. Int J Pharm. 2010 May 31; 391(1-2):79-89.
    View in: PubMed
    Score: 0,305
  12. Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS. Adv Drug Deliv Rev. 2010 Mar 18; 62(4-5):532-46.
    View in: PubMed
    Score: 0,300
  13. Mechanistic evaluation of alginate-HEC gelisphere compacts for controlled intrastriatal nicotine release in Parkinson's disease. J Pharm Sci. 2009 Jun; 98(6):2059-72.
    View in: PubMed
    Score: 0,290
  14. Functionalised Carbon Nanotubes: Promising Drug Delivery Vehicles for Neurovascular Disorder Intervention. AAPS PharmSciTech. 2023 Oct 02; 24(7):201.
    View in: PubMed
    Score: 0,196
  15. Intravaginal Drug Delivery Systems to Treat the Genitourinary Syndrome of Menopause: Towards the Design of Safe and Efficacious Estrogen-loaded Prototypes. J Pharm Sci. 2023 06; 112(6):1566-1585.
    View in: PubMed
    Score: 0,188
  16. Recent patents on water-soluble polysaccharides for advanced drug delivery, tissue engineering and regenerative medicine. Pharm Pat Anal. 2022 Mar; 11(2):75-88.
    View in: PubMed
    Score: 0,180
  17. Lipopolysaccharide Nanosystems for the Enhancement of Oral Bioavailability. AAPS PharmSciTech. 2021 Sep 30; 22(7):242.
    View in: PubMed
    Score: 0,171
  18. Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present). Expert Opin Ther Pat. 2021 Sep; 31(9):851-865.
    View in: PubMed
    Score: 0,165
  19. Lipid-drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery. Pharm Dev Technol. 2020 Mar; 25(3):267-280.
    View in: PubMed
    Score: 0,151
  20. Hypothesis: Can drug-loaded platelets be used as delivery vehicles for blood-brain barrier penetration? Med Hypotheses. 2019 Apr; 125:75-78.
    View in: PubMed
    Score: 0,142
  21. Therapeutic applications and pharmacoeconomics of microneedle technology. Expert Rev Pharmacoecon Outcomes Res. 2018 08; 18(4):359-369.
    View in: PubMed
    Score: 0,136
  22. Drug Delivery Strategies for Antivirals against Hepatitis B Virus. Viruses. 2018 05 17; 10(5).
    View in: PubMed
    Score: 0,135
  23. Synthesis and biocompatibility of dual-responsive thermosonic injectable organogels based on crosslinked N-(isopropyl acrylamide) for tumour microenvironment targeting. Mater Sci Eng C Mater Biol Appl. 2018 Sep 01; 90:148-158.
    View in: PubMed
    Score: 0,134
  24. In Vitro-In Vivo Evaluation of an Oral Ghost Drug Delivery Device for the Delivery of Salmon Calcitonin. J Pharm Sci. 2018 06; 107(6):1605-1614.
    View in: PubMed
    Score: 0,133
  25. Outlook on the Application of Metal-Liganded Bioactives for Stimuli-Responsive Release. Molecules. 2017 Nov 26; 22(12).
    View in: PubMed
    Score: 0,131
  26. Submicron Matrices Embedded in a Polymeric Caplet for Extended Intravaginal Delivery of Zidovudine. AAPS J. 2017 11; 19(6):1745-1759.
    View in: PubMed
    Score: 0,128
  27. Development of an injectable pseudo-bone thermo-gel for application in small bone fractures. Int J Pharm. 2017 Mar 30; 520(1-2):39-48.
    View in: PubMed
    Score: 0,123
  28. In Vitro and In Vivo Evaluation of a Hydrogel-Based Microneedle Device for Transdermal Electro-Modulated Analgesia. J Pharm Sci. 2017 04; 106(4):1111-1116.
    View in: PubMed
    Score: 0,123
  29. Design and characterization of neurodurable gellan-xanthan pH-responsive hydrogels for controlled drug delivery. Expert Opin Drug Deliv. 2017 03; 14(3):291-306.
    View in: PubMed
    Score: 0,123
  30. Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders. Pharm Dev Technol. 2017 Jun; 22(4):476-486.
    View in: PubMed
    Score: 0,118
  31. Design of an In Situ Cross-Linked Eutectic Tablet for Enhanced Delivery of Gastro-Sensitive Proteins and Peptides. J Pharm Sci. 2016 07; 105(7):2086-98.
    View in: PubMed
    Score: 0,118
  32. Polymeric networks for controlled release of drugs: a patent review. Expert Opin Ther Pat. 2016 Jun; 26(6):703-17.
    View in: PubMed
    Score: 0,117
  33. Poly(ethylene glycol) enclatherated pectin-mucin submicron matrices for intravaginal anti-HIV-1 drug delivery. Int J Pharm. 2016 Apr 30; 503(1-2):16-28.
    View in: PubMed
    Score: 0,116
  34. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain. Int J Pharm. 2016 Mar 16; 500(1-2):196-209.
    View in: PubMed
    Score: 0,115
  35. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery. Curr Pharm Des. 2016; 22(46):6988-6997.
    View in: PubMed
    Score: 0,115
  36. Ex vivo evaluation of a microneedle array device for transdermal application. Int J Pharm. 2015 Dec 30; 496(2):351-9.
    View in: PubMed
    Score: 0,113
  37. Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures. Int J Nanomedicine. 2015; 10:2191-206.
    View in: PubMed
    Score: 0,108
  38. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders. J Pharm Sci. 2015 Apr; 104(4):1213-29.
    View in: PubMed
    Score: 0,107
  39. Disulphide-thiol chemistry: a multi-faceted tool for macromolecular design and synthesis of polyfunctional materials for specialized drug delivery. Curr Drug Deliv. 2015; 12(3):282-98.
    View in: PubMed
    Score: 0,107
  40. Design of chitospheres loaded with pristine polymer particles for extended drug delivery via polyelectrolyte complexation and particulate leaching. Int J Pharm. 2015 Feb 01; 479(1):189-206.
    View in: PubMed
    Score: 0,107
  41. In silico mechanistic disposition and in vivo evaluation of zero-order drug release from a novel triple-layered tablet matrix. Expert Opin Drug Deliv. 2015 May; 12(5):693-713.
    View in: PubMed
    Score: 0,107
  42. Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer. Expert Opin Drug Deliv. 2015 Apr; 12(4):613-34.
    View in: PubMed
    Score: 0,105
  43. In vivo evaluation of a mucoadhesive polymeric caplet for intravaginal anti-HIV-1 delivery and development of a molecular mechanistic model for thermochemical characterization. Drug Dev Ind Pharm. 2015; 41(8):1274-87.
    View in: PubMed
    Score: 0,104
  44. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. Biotechnol Adv. 2014 Nov 15; 32(7):1269-1282.
    View in: PubMed
    Score: 0,104
  45. A novel pH-responsive interpolyelectrolyte hydrogel complex for the oral delivery of levodopa. Part I. IPEC modeling and synthesis. J Biomed Mater Res A. 2015 Mar; 103(3):1077-84.
    View in: PubMed
    Score: 0,103
  46. Current advances in the fabrication of microneedles for transdermal delivery. J Control Release. 2014 Jul 10; 185:130-8.
    View in: PubMed
    Score: 0,102
  47. In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model. Int J Pharm. 2014 May 15; 466(1-2):296-306.
    View in: PubMed
    Score: 0,101
  48. Patient-controlled analgesia: therapeutic interventions using transdermal electro-activated and electro-modulated drug delivery. J Pharm Sci. 2014 Feb; 103(2):353-66.
    View in: PubMed
    Score: 0,099
  49. An interfacially plasticized electro-responsive hydrogel for transdermal electro-activated and modulated (TEAM) drug delivery. Int J Pharm. 2014 Feb 28; 462(1-2):52-65.
    View in: PubMed
    Score: 0,099
  50. A novel pH-sensitive interferon-ß (INF-ß) oral delivery system for application in multiple sclerosis. Int J Pharm. 2013 Nov 18; 456(2):459-72.
    View in: PubMed
    Score: 0,097
  51. A novel multilayered multidisk oral tablet for chronotherapeutic drug delivery. Biomed Res Int. 2013; 2013:569470.
    View in: PubMed
    Score: 0,097
  52. Flavonoids and polymer derivatives as CYP3A4 inhibitors for improved oral drug bioavailability. J Pharm Sci. 2013 Feb; 102(2):541-55.
    View in: PubMed
    Score: 0,092
  53. Oral drug delivery systems comprising altered geometric configurations for controlled drug delivery. Int J Mol Sci. 2012; 13(1):18-43.
    View in: PubMed
    Score: 0,087
  54. Optimization of a dual mechanism gastrofloatable and gastroadhesive delivery system for narrow absorption window drugs. AAPS PharmSciTech. 2012 Mar; 13(1):1-15.
    View in: PubMed
    Score: 0,086
  55. Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery. Int J Mol Sci. 2011; 12(9):6194-225.
    View in: PubMed
    Score: 0,085
  56. Advanced preformulation investigations for the development of a lead intravaginal bioadhesive polymeric device. Drug Dev Ind Pharm. 2012 Mar; 38(3):271-93.
    View in: PubMed
    Score: 0,085
  57. Optimization of a polymer composite employing molecular mechanic simulations and artificial neural networks for a novel intravaginal bioadhesive drug delivery device. Pharm Dev Technol. 2012 Jul-Aug; 17(4):407-20.
    View in: PubMed
    Score: 0,081
  58. A composite polyelectrolytic matrix for controlled oral drug delivery. AAPS PharmSciTech. 2011 Mar; 12(1):227-38.
    View in: PubMed
    Score: 0,081
  59. Self-assembling peptides: implications for patenting in drug delivery and tissue engineering. Recent Pat Drug Deliv Formul. 2011 Jan; 5(1):24-51.
    View in: PubMed
    Score: 0,081
  60. Ocular drug delivery - a look towards nanobioadhesives. Expert Opin Drug Deliv. 2011 Jan; 8(1):71-94.
    View in: PubMed
    Score: 0,081
  61. A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Curr Drug Deliv. 2010 Dec; 7(5):370-88.
    View in: PubMed
    Score: 0,081
  62. In vivo evaluation of the release of zidovudine and polystyrene sulfonate from a dual intravaginal bioadhesive polymeric device in the pig model. J Pharm Sci. 2011 Apr; 100(4):1416-35.
    View in: PubMed
    Score: 0,080
  63. A review of multi-responsive membranous systems for rate-modulated drug delivery. AAPS PharmSciTech. 2010 Mar; 11(1):441-59.
    View in: PubMed
    Score: 0,077
  64. Levodopa delivery systems: advancements in delivery of the gold standard. Expert Opin Drug Deliv. 2010 Feb; 7(2):203-24.
    View in: PubMed
    Score: 0,076
  65. A mathematical approach for the simultaneous in vitro spectrophotometric analysis of rifampicin and isoniazid from modified-release anti-TB drug delivery systems. Curr Drug Deliv. 2010 Jan; 7(1):5-12.
    View in: PubMed
    Score: 0,076
  66. Gastroretentive drug delivery systems: current developments in novel system design and evaluation. Curr Drug Deliv. 2009 Oct; 6(5):451-60.
    View in: PubMed
    Score: 0,074
  67. Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol. 2009 Aug; 88(4):272-85.
    View in: PubMed
    Score: 0,073
  68. Stimuli-responsive polymers and their applications in drug delivery. Biomed Mater. 2009 Apr; 4(2):022001.
    View in: PubMed
    Score: 0,071
  69. Rapidly disintegrating oramucosal drug delivery technologies. Pharm Dev Technol. 2009; 14(6):588-601.
    View in: PubMed
    Score: 0,071
  70. Drug delivery technologies for chronotherapeutic applications. Pharm Dev Technol. 2009; 14(6):602-12.
    View in: PubMed
    Score: 0,071
  71. In vitro and ex vivo bioadhesivity analysis of polymeric intravaginal caplets using physicomechanics and computational structural modeling. Int J Pharm. 2009 Mar 31; 370(1-2):151-9.
    View in: PubMed
    Score: 0,070
  72. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system. Drug Deliv. 2007 Jul; 14(5):309-18.
    View in: PubMed
    Score: 0,064
  73. Patenting of nanopharmaceuticals in drug delivery: no small issue. Recent Pat Drug Deliv Formul. 2007; 1(2):131-42.
    View in: PubMed
    Score: 0,061
  74. Biomedical Applications of polymeric micelles in the treatment of diabetes mellitus: Current success and future approaches. Expert Opin Drug Deliv. 2022 07; 19(7):771-793.
    View in: PubMed
    Score: 0,045
  75. Advances in designing of polymeric micelles for biomedical application in brain related diseases. Chem Biol Interact. 2022 Jul 01; 361:109960.
    View in: PubMed
    Score: 0,044
  76. Carbon Dots as Nanotherapeutics for Biomedical Application. Curr Pharm Des. 2020; 26(19):2207-2221.
    View in: PubMed
    Score: 0,038
  77. In situ thermo-co-electroresponsive mucogel for controlled release of bioactive agent. Int J Pharm. 2019 Mar 25; 559:255-270.
    View in: PubMed
    Score: 0,035
  78. Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis. J Pharm Pharm Sci. 2018; 21(1):94-109.
    View in: PubMed
    Score: 0,033
  79. InVitro, Ex Vivo, and In Vivo Evaluation of a Dual pH/Redox Responsive Nanoliposomal Sludge for Transdermal Drug Delivery. J Pharm Sci. 2018 04; 107(4):1028-1036.
    View in: PubMed
    Score: 0,033
  80. Development of a Novel Polymeric Nanocomposite Complex for Drugs with Low Bioavailability. AAPS PharmSciTech. 2018 Jan; 19(1):303-314.
    View in: PubMed
    Score: 0,032
  81. Targeted nanotechnologies for cancer intervention: a patent review (2010-2016). Expert Opin Ther Pat. 2017 Sep; 27(9):1005-1019.
    View in: PubMed
    Score: 0,032
  82. Development of a Gastric Absorptive, Immediate Responsive, Oral Protein-Loaded Versatile Polymeric Delivery System. AAPS PharmSciTech. 2017 Oct; 18(7):2479-2493.
    View in: PubMed
    Score: 0,031
  83. A Review of Injectable Polymeric Hydrogel Systems for Application in Bone Tissue Engineering. Molecules. 2016 Nov 21; 21(11).
    View in: PubMed
    Score: 0,030
  84. A Dual-Biotic System for the Concurrent Delivery of Antibiotics and Probiotics: In Vitro, Ex Vivo, In Vivo and In Silico Evaluation and Correlation. Pharm Res. 2016 12; 33(12):3057-3071.
    View in: PubMed
    Score: 0,030
  85. Design and evaluation of an oral multiparticulate system for dual delivery of amoxicillin and Lactobacillus acidophilus. Future Microbiol. 2016 09; 11:1133-45.
    View in: PubMed
    Score: 0,030
  86. Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular Delivery. Molecules. 2016 Jul 30; 21(8).
    View in: PubMed
    Score: 0,030
  87. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability. Pharm Dev Technol. 2017 Mar; 22(2):283-295.
    View in: PubMed
    Score: 0,030
  88. A dual pH/Redox responsive copper-ligand nanoliposome bioactive complex for the treatment of chronic inflammation. Int J Pharm. 2016 Jul 25; 509(1-2):348-359.
    View in: PubMed
    Score: 0,029
  89. Functionalized Nanolipobubbles Embedded Within a Nanocomposite Hydrogel: a Molecular Bio-imaging and Biomechanical Analysis of the System. AAPS PharmSciTech. 2017 Apr; 18(3):671-685.
    View in: PubMed
    Score: 0,029
  90. In Vivo Evaluation of a PEO-Gellan Gum Semi-Interpenetrating Polymer Network for the Oral Delivery of Sulpiride. AAPS PharmSciTech. 2017 Apr; 18(3):654-670.
    View in: PubMed
    Score: 0,029
  91. Enhancement of the Oral Bioavailability of Felodipine Employing 8-Arm-Poly(Ethylene Glycol): In Vivo, In Vitro and In Silico Evaluation. AAPS PharmSciTech. 2017 Apr; 18(3):617-628.
    View in: PubMed
    Score: 0,029
  92. Design of an Inflammation-Sensitive Polyelectrolyte-Based Topical Drug Delivery System for Arthritis. AAPS PharmSciTech. 2016 Oct; 17(5):1075-85.
    View in: PubMed
    Score: 0,028
  93. Development and in vivo evaluation of an implantable nano-enabled multipolymeric scaffold for the management of AIDS dementia complex (ADC). Int J Pharm. 2015 Dec 30; 496(2):863-77.
    View in: PubMed
    Score: 0,028
  94. A novel bile salts-lipase polymeric film-infused minitablet system for enhanced oral delivery of cholecalciferol. Pharm Dev Technol. 2016 Nov; 21(7):832-846.
    View in: PubMed
    Score: 0,028
  95. An electro-conductive fluid as a responsive implant for the controlled stimuli-release of diclofenac sodium. Pharm Dev Technol. 2016 Nov; 21(7):875-886.
    View in: PubMed
    Score: 0,028
  96. An optimized gastroretentive nanosystem for the delivery of levodopa. Int J Pharm. 2015 Oct 15; 494(1):49-65.
    View in: PubMed
    Score: 0,028
  97. A Co-blended Locust Bean Gum and Polymethacrylate-NaCMC Matrix to Achieve Zero-Order Release via Hydro-Erosive Modulation. AAPS PharmSciTech. 2015 Dec; 16(6):1377-89.
    View in: PubMed
    Score: 0,027
  98. In vitro, ex vivo and in silico mechanistic elucidation of the performance of an optimized porosity-controlled multi-elemental transbuccal system. Pharm Res. 2015 Jul; 32(7):2384-409.
    View in: PubMed
    Score: 0,027
  99. A review of formulation techniques that impact the disintegration and mechanical properties of oradispersible drug delivery technologies. Pharm Dev Technol. 2016; 21(3):354-66.
    View in: PubMed
    Score: 0,027
  100. A comprehensive review of advanced biopolymeric wound healing systems. J Pharm Sci. 2014 Aug; 103(8):2211-30.
    View in: PubMed
    Score: 0,026
  101. Prolonged delivery of ciprofloxacin and diclofenac sodium from a polymeric fibre device for the treatment of periodontal disease. Biomed Res Int. 2013; 2013:460936.
    View in: PubMed
    Score: 0,025
  102. A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation. AAPS PharmSciTech. 2014 Feb; 15(1):29-43.
    View in: PubMed
    Score: 0,024
  103. In vitro, in vivo, and in silico evaluation of the bioresponsive behavior of an intelligent intraocular implant. Pharm Res. 2014 Mar; 31(3):607-34.
    View in: PubMed
    Score: 0,024
  104. A review of topically administered mini-tablets for drug delivery to the anterior segment of the eye. J Pharm Pharmacol. 2014 Apr; 66(4):490-506.
    View in: PubMed
    Score: 0,024
  105. Vitamin D therapy and related metabolomics: is the calciferol dose and form the only requirements for successful clinical therapeutics? Med Hypotheses. 2013 Oct; 81(4):656-63.
    View in: PubMed
    Score: 0,024
  106. A review of integrating electroactive polymers as responsive systems for specialized drug delivery applications. J Biomed Mater Res A. 2014 Jun; 102(6):2039-54.
    View in: PubMed
    Score: 0,024
  107. Design of an anti-inflammatory composite nanosystem and evaluation of its potential for ocular drug delivery. J Pharm Sci. 2013 Aug; 102(8):2780-805.
    View in: PubMed
    Score: 0,024
  108. Integration of biosensors and drug delivery technologies for early detection and chronic management of illness. Sensors (Basel). 2013 Jun 14; 13(6):7680-713.
    View in: PubMed
    Score: 0,024
  109. Physicomechanical characterization and optimization of EDTA-mPEG and Avicel®-EDTA-mPEG in situ melt dispersion mini-pellets. AAPS PharmSciTech. 2013 Sep; 14(3):935-49.
    View in: PubMed
    Score: 0,024
  110. A novel pH-dependant and double crosslinked polymethacrylate-based polysphere matrix for enteric delivery of isoniazid. Pharm Dev Technol. 2013 Sep-Oct; 18(5):1066-77.
    View in: PubMed
    Score: 0,022
  111. The application of a crosslinked pectin-based wafer matrix for gradual buccal drug delivery. J Biomed Mater Res B Appl Biomater. 2012 May; 100(4):1029-43.
    View in: PubMed
    Score: 0,022
  112. Comparing the mucoadhesivity and drug release mechanisms of various polymer-containing propranolol buccal tablets. Drug Dev Ind Pharm. 2008 Feb; 34(2):189-98.
    View in: PubMed
    Score: 0,017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.